期刊文献+

丁咯地尔与肌氨肽苷联合治疗糖尿病周围神经病疗效观察 被引量:7

Observation Of Curative Effect Of Buflomedil Injection And Muscular Amino Acids And Peptides And Nucleosides Injection For Treating Diabetic Peripheral Neuropathy
下载PDF
导出
摘要 目的:观察丁咯地尔与肌氨肽苷联合治疗糖尿病周围神经病变的疗效。方法:86例患者随机分为治疗组和对照组各43例。治疗组:在常规治疗基础上应用丁咯地尔150mg加入生理盐水250ml、肌氨肽苷8ml加入生理盐水250ml中静脉滴注,每日一次;对照组:在常规治疗基础上维生素B1100mg、维生素B12500μg肌肉注射,每日一次。连续治疗4周。结果:治疗组:显效29例,有效9例,无效5例;总有效率88.3%,明显高于对照组的62.8%,经秩和检验P<0.01,且未见明显副作用。结论:丁咯地尔与肌氨肽苷联合治疗糖尿病周围神经病变是较理想的药物。 Objective: To observe the effect of buflomedil injection and muscular amino acids and peptides and nucleosides injection to treat diabetic peripheral neuropathy. Methods:86 patients with diabetic peripheral neuropathy were divided randomly into two groups. 43 cases in the treated group were treated with routine treatment + buflomedil injection + Muscular amino acids and peptides and nucleosides injection; 43 cases in the control group were treated with routine treatment + vitamin B1 + vitamin B12. Results: The effective rate of treated group was 88.3 %, higher than that of the control group(62.8% ) (P〈0.01). There was no obvious side effect. Conclusion: Buflomedil injection and Muscular amino acids and peptides and nucleosides injection are effective medicine for treating diabetic peripheral neuropathy.
作者 李建明
出处 《脑与神经疾病杂志》 2008年第1期17-18,22,共3页 Journal of Brain and Nervous Diseases
关键词 丁咯地尔 肌氨肽苷 糖尿病周围神经病变 buflomedil muscular amino acids and peptides and nucleosides diabetic peripheral neuropathy
  • 相关文献

参考文献6

二级参考文献24

  • 1张蜀平.糖尿病神经病变发生机制研究的若干进展[J].国外医学(内分泌学分册),1996,16(4):184-187. 被引量:189
  • 2戴自英.实用内科学,第9版[M].北京:人民卫生出版社,1994.86.
  • 3上海医科大学.医用药理学[M].北京:人民卫生出版社,1976.105.
  • 4Cameron N E,Eaton S E,Cotter M A, et al . Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy[J]. Diabetologia, 2001,44(11) : 1973-1988.
  • 5Haler M C, Ivey F M, Gyure K A, et al. Thrombomodulin deficiency in human diabetic nerve microvasculature [J]. Diabetes, 2002,51(6): 1957-1963.
  • 6Aso Y, Fujiwara Y, Tayama K, a al. Elevation of von Willebrand factor in plasma in diabetic patients with neuropathic foot ulceration[J]. Diabet Med, 2002,19(1) : 19-26.
  • 7Nakayama M, Nakamaru J, Hamada Y, a al . Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy[J]. Diabetes Care,2001,24(6) : 1093-1098.
  • 8Zochodne D W. Diabetic neuropathies : features and mechanisms[J]. Brain Pathol,1999,9(2) :369-391.
  • 9Verrotti A,Giuva P T, Morgese G, et al . New trends in the etipathogenesis of diabetic peripheral neuropathy[J]. J Child Neurol, 2001,16(6) : 389-394.
  • 10Conti G, Scarpini E, Baron P, mal . Macrophage infiltration and death in the nerve during the early phases of experimental diabetic neuropathy: a process concomitant with endoneurial induction of IL-lbeta and p75NTR[J]. J Neurol Sci, 2002,195(1) : 35-40.

共引文献56

同被引文献56

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部